Supreme Court Slams Central Government Over Excessive Hospital Bills and Drug Markup


NEW DELHI — In a scathing rebuke on Tuesday, the Supreme Court of India hauled the central administration over the coals for failing to curb exorbitant medical fees and runaway prescription drug prices, delivering sharp remarks from the bench regarding the commercialization of patient care.
The judicial reprimand shines a glaring spotlight on the escalating financial burdens faced by ordinary citizens seeking medical attention, addressing a long-standing crisis where private healthcare facilities frequently impose astronomical markups on essential consumables, diagnostics, and therapeutics.
According to reports by the Nagaland Post, the apex court bench openly challenged federal authorities during the proceedings, demanding to know if modern medical institutions could genuinely justify predatory billing models under the pretext of sustaining institutional infrastructure.
Legal experts anticipate that this stern judicial intervention will compel the Ministry of Health and Family Welfare to fast-track stricter pricing caps and enforce rigorous compliance mechanisms to protect patients from financial exploitation in hospitals nationwide.